vs
Grindr Inc.（GRND）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Grindr Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$126.0M vs $75.5M），Grindr Inc.同比增速更快（29.0% vs 27.7%），Grindr Inc.自由现金流更多（$24.5M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 29.3%）
Grindr是面向LGBTQ群体的定位类社交应用，基于地理位置匹配功能帮助同群体用户便捷建立联系、拓展社交圈，是全球范围内该群体中认知度较高的社交服务平台之一。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GRND vs PBYI — 直观对比
营收规模更大
GRND
是对方的1.7倍
$75.5M
营收增速更快
GRND
高出1.3%
27.7%
自由现金流更多
GRND
多$10.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
29.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $126.0M | $75.5M |
| 净利润 | $20.3M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 24.9% | 22.7% |
| 净利率 | 16.1% | — |
| 营收同比 | 29.0% | 27.7% |
| 净利润同比 | 116.4% | — |
| 每股收益（稀释后） | $0.10 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GRNDPBYI
| Q4 25 | $126.0M | $75.5M | ||
| Q3 25 | $115.8M | $54.5M | ||
| Q2 25 | $104.2M | $52.4M | ||
| Q1 25 | $93.9M | $46.0M | ||
| Q4 24 | $97.6M | $59.1M | ||
| Q3 24 | $89.3M | $80.5M | ||
| Q2 24 | $82.3M | $47.1M | ||
| Q1 24 | $75.3M | $43.8M |
净利润GRNDPBYI
| Q4 25 | $20.3M | — | ||
| Q3 25 | $30.8M | $8.8M | ||
| Q2 25 | $16.6M | $5.9M | ||
| Q1 25 | $27.0M | $3.0M | ||
| Q4 24 | $-123.9M | — | ||
| Q3 24 | $24.7M | $20.3M | ||
| Q2 24 | $-22.4M | $-4.5M | ||
| Q1 24 | $-9.4M | $-4.8M |
毛利率GRNDPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率GRNDPBYI
| Q4 25 | 24.9% | 22.7% | ||
| Q3 25 | 39.1% | 17.6% | ||
| Q2 25 | 23.4% | 12.7% | ||
| Q1 25 | 27.0% | 8.7% | ||
| Q4 24 | 20.9% | 22.6% | ||
| Q3 24 | 31.8% | 27.4% | ||
| Q2 24 | 29.8% | -4.6% | ||
| Q1 24 | 25.6% | -5.3% |
净利率GRNDPBYI
| Q4 25 | 16.1% | — | ||
| Q3 25 | 26.6% | 16.2% | ||
| Q2 25 | 16.0% | 11.2% | ||
| Q1 25 | 28.8% | 6.5% | ||
| Q4 24 | -126.9% | — | ||
| Q3 24 | 27.6% | 25.2% | ||
| Q2 24 | -27.2% | -9.6% | ||
| Q1 24 | -12.5% | -11.0% |
每股收益（稀释后）GRNDPBYI
| Q4 25 | $0.10 | $0.26 | ||
| Q3 25 | $0.16 | $0.17 | ||
| Q2 25 | $0.08 | $0.12 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $-0.65 | $0.40 | ||
| Q3 24 | $0.09 | $0.41 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $-0.05 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.0M | $97.5M |
| 总债务越低越好 | $395.9M | $22.7M |
| 股东权益账面价值 | $47.0M | $130.3M |
| 总资产 | $531.0M | $216.3M |
| 负债/权益比越低杠杆越低 | 8.42× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GRNDPBYI
| Q4 25 | $87.0M | $97.5M | ||
| Q3 25 | $6.3M | $94.4M | ||
| Q2 25 | $120.8M | $96.0M | ||
| Q1 25 | $255.9M | $93.2M | ||
| Q4 24 | $59.2M | $101.0M | ||
| Q3 24 | $39.1M | $96.7M | ||
| Q2 24 | $16.3M | $96.8M | ||
| Q1 24 | $21.5M | $107.2M |
总债务GRNDPBYI
| Q4 25 | $395.9M | $22.7M | ||
| Q3 25 | $279.9M | $34.0M | ||
| Q2 25 | $283.5M | $45.3M | ||
| Q1 25 | $287.0M | $56.7M | ||
| Q4 24 | $290.6M | $68.0M | ||
| Q3 24 | $294.1M | $79.3M | ||
| Q2 24 | $297.7M | $90.7M | ||
| Q1 24 | $315.0M | $102.0M |
股东权益GRNDPBYI
| Q4 25 | $47.0M | $130.3M | ||
| Q3 25 | $71.0M | $115.3M | ||
| Q2 25 | $187.7M | $104.7M | ||
| Q1 25 | $319.8M | $97.1M | ||
| Q4 24 | $-131.6M | $92.1M | ||
| Q3 24 | $-13.4M | $71.1M | ||
| Q2 24 | $-41.7M | $48.5M | ||
| Q1 24 | $-22.0M | $51.0M |
总资产GRNDPBYI
| Q4 25 | $531.0M | $216.3M | ||
| Q3 25 | $439.2M | $202.9M | ||
| Q2 25 | $547.6M | $194.9M | ||
| Q1 25 | $679.4M | $196.2M | ||
| Q4 24 | $479.1M | $213.3M | ||
| Q3 24 | $456.3M | $220.7M | ||
| Q2 24 | $435.0M | $205.0M | ||
| Q1 24 | $437.7M | $214.1M |
负债/权益比GRNDPBYI
| Q4 25 | 8.42× | 0.17× | ||
| Q3 25 | 3.94× | 0.30× | ||
| Q2 25 | 1.51× | 0.43× | ||
| Q1 25 | 0.90× | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $24.8M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $24.5M | $14.4M |
| 自由现金流率自由现金流/营收 | 19.5% | 19.1% |
| 资本支出强度资本支出/营收 | 0.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.22× | — |
| 过去12个月自由现金流最近4个季度 | $140.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流GRNDPBYI
| Q4 25 | $24.8M | $14.4M | ||
| Q3 25 | $55.4M | $9.7M | ||
| Q2 25 | $37.5M | $14.1M | ||
| Q1 25 | $23.8M | $3.6M | ||
| Q4 24 | $29.5M | $15.6M | ||
| Q3 24 | $29.1M | $11.0M | ||
| Q2 24 | $15.8M | $1.0M | ||
| Q1 24 | $20.4M | $11.2M |
自由现金流GRNDPBYI
| Q4 25 | $24.5M | $14.4M | ||
| Q3 25 | $55.2M | $9.7M | ||
| Q2 25 | $37.3M | $14.1M | ||
| Q1 25 | $23.7M | $3.6M | ||
| Q4 24 | $29.3M | $15.6M | ||
| Q3 24 | $28.8M | $11.0M | ||
| Q2 24 | $15.7M | $1.0M | ||
| Q1 24 | $20.3M | — |
自由现金流率GRNDPBYI
| Q4 25 | 19.5% | 19.1% | ||
| Q3 25 | 47.7% | 17.7% | ||
| Q2 25 | 35.8% | 26.8% | ||
| Q1 25 | 25.2% | 7.7% | ||
| Q4 24 | 30.0% | 26.4% | ||
| Q3 24 | 32.2% | 13.7% | ||
| Q2 24 | 19.0% | 2.1% | ||
| Q1 24 | 26.9% | — |
资本支出强度GRNDPBYI
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.3% | 0.0% |
现金转化率GRNDPBYI
| Q4 25 | 1.22× | — | ||
| Q3 25 | 1.80× | 1.10× | ||
| Q2 25 | 2.25× | 2.41× | ||
| Q1 25 | 0.88× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.18× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GRND
| License And Service | $102.9M | 82% |
| Advertising | $23.1M | 18% |
PBYI
暂无分部数据
